170 related articles for article (PubMed ID: 23990312)
1. The importance of villous physiology and morphology in mechanistic physiologically-based pharmacokinetic models.
Chen EP; Tai G; Ellens H
Pharm Res; 2014 Feb; 31(2):305-21. PubMed ID: 23990312
[TBL] [Abstract][Full Text] [Related]
2. Critical Impact of Drug-Drug Interactions via Intestinal CYP3A in the Risk Assessment of Weak Perpetrators Using Physiologically Based Pharmacokinetic Models.
Yamada M; Inoue SI; Sugiyama D; Nishiya Y; Ishizuka T; Watanabe A; Watanabe K; Yamashita S; Watanabe N
Drug Metab Dispos; 2020 Apr; 48(4):288-296. PubMed ID: 31996361
[TBL] [Abstract][Full Text] [Related]
3. Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John's Wort.
Adiwidjaja J; Boddy AV; McLachlan AJ
Clin Pharmacokinet; 2019 Jul; 58(7):911-926. PubMed ID: 30675694
[TBL] [Abstract][Full Text] [Related]
4. Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data.
Gertz M; Harrison A; Houston JB; Galetin A
Drug Metab Dispos; 2010 Jul; 38(7):1147-58. PubMed ID: 20368326
[TBL] [Abstract][Full Text] [Related]
5. Drug-Drug Interaction Risk Assessment of Esaxerenone as a Perpetrator by In Vitro Studies and Static and Physiologically Based Pharmacokinetic Models.
Yamada M; Ishizuka T; Inoue SI; Rozehnal V; Fischer T; Sugiyama D
Drug Metab Dispos; 2020 Sep; 48(9):769-777. PubMed ID: 32616542
[TBL] [Abstract][Full Text] [Related]
6. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
[TBL] [Abstract][Full Text] [Related]
7. PBPK modeling of CYP3A and P-gp substrates to predict drug-drug interactions in patients undergoing Roux-en-Y gastric bypass surgery.
Chen KF; Chan LN; Lin YS
J Pharmacokinet Pharmacodyn; 2020 Oct; 47(5):493-512. PubMed ID: 32710209
[TBL] [Abstract][Full Text] [Related]
8. Utility of Pooled Cryopreserved Human Enterocytes as an In vitro Model for Assessing Intestinal Clearance and Drug-Drug Interactions.
Wong S; Doshi U; Vuong P; Liu N; Tay S; Le H; Kosaka M; Kenny JR; Li AP; Yan Z
Drug Metab Lett; 2018; 12(1):3-13. PubMed ID: 29237391
[TBL] [Abstract][Full Text] [Related]
9. Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin.
Quinney SK; Zhang X; Lucksiri A; Gorski JC; Li L; Hall SD
Drug Metab Dispos; 2010 Feb; 38(2):241-8. PubMed ID: 19884323
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Intestinal and Hepatic CYP3A-Mediated Metabolism of Midazolam in Children Using a Physiological Population Pharmacokinetic Modelling Approach.
Brussee JM; Yu H; Krekels EHJ; Palić S; Brill MJE; Barrett JS; Rostami-Hodjegan A; de Wildt SN; Knibbe CAJ
Pharm Res; 2018 Jul; 35(9):182. PubMed ID: 30062590
[TBL] [Abstract][Full Text] [Related]
11. Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption.
Badhan R; Penny J; Galetin A; Houston JB
J Pharm Sci; 2009 Jun; 98(6):2180-97. PubMed ID: 18855913
[TBL] [Abstract][Full Text] [Related]
12. The nested enzyme-within-enterocyte (NEWE) turnover model for predicting dynamic drug and disease effects on the gut wall.
Darwich AS; Burt HJ; Rostami-Hodjegan A
Eur J Pharm Sci; 2019 Apr; 131():195-207. PubMed ID: 30776469
[TBL] [Abstract][Full Text] [Related]
13. Physiologically based pharmacokinetic modeling of intestinal first-pass metabolism of CYP3A substrates with high intestinal extraction.
Gertz M; Houston JB; Galetin A
Drug Metab Dispos; 2011 Sep; 39(9):1633-42. PubMed ID: 21632965
[TBL] [Abstract][Full Text] [Related]
14. Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles.
Peters SA
Clin Pharmacokinet; 2008; 47(4):245-59. PubMed ID: 18336054
[TBL] [Abstract][Full Text] [Related]
15. A Novel Study Design Using Continuous Intravenous and Intraduodenal Infusions of Midazolam and Voriconazole for Mechanistic Quantitative Assessment of Hepatic and Intestinal CYP3A Inhibition.
Li X; Junge L; Taubert M; von Georg A; Dahlinger D; Starke C; Frechen S; Stelzer C; Kinzig M; Sörgel F; Jaehde U; Töx U; Goeser T; Fuhr U
J Clin Pharmacol; 2020 Sep; 60(9):1237-1253. PubMed ID: 32427354
[TBL] [Abstract][Full Text] [Related]
16. Application of Cryopreserved Human Intestinal Mucosa and Cryopreserved Human Enterocytes in the Evaluation of Herb-Drug Interactions: Evaluation of CYP3A Inhibitory Potential of Grapefruit Juice and Commercial Formulations of Twenty-Nine Herbal Supplements.
Loretz C; Ho MD; Alam N; Mitchell W; Li AP
Drug Metab Dispos; 2020 Oct; 48(10):1084-1091. PubMed ID: 32719085
[TBL] [Abstract][Full Text] [Related]
17. A New Intestinal Model for Analysis of Drug Absorption and Interactions Considering Physiological Translocation of Contents.
Asano S; Yoshitomo A; Hozuki S; Sato H; Kazuki Y; Hisaka A
Drug Metab Dispos; 2021 Jul; 49(7):581-591. PubMed ID: 33962977
[TBL] [Abstract][Full Text] [Related]
18. Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates - an evaluation and case study using GastroPlus.
Heikkinen AT; Baneyx G; Caruso A; Parrott N
Eur J Pharm Sci; 2012 Sep; 47(2):375-86. PubMed ID: 22759901
[TBL] [Abstract][Full Text] [Related]
19. Drug Interactions for Low-Dose Inhaled Nemiralisib: A Case Study Integrating Modeling, In Vitro, and Clinical Investigations.
Patel A; Wilson R; Harrell AW; Taskar KS; Taylor M; Tracey H; Riddell K; Georgiou A; Cahn AP; Marotti M; Hessel EM
Drug Metab Dispos; 2020 Apr; 48(4):307-316. PubMed ID: 32009006
[TBL] [Abstract][Full Text] [Related]
20. A new physiologically based pharmacokinetic model for the prediction of gastrointestinal drug absorption: translocation model.
Ando H; Hisaka A; Suzuki H
Drug Metab Dispos; 2015 Apr; 43(4):590-602. PubMed ID: 25616403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]